Latest News

Inhaled insulin Afrezza offers a rapid-acting alternative for children with type 1 diabetes, enhancing blood glucose control and patient satisfaction.

The integration of artificial intelligence into health care represents a shift in how pharmacists approach medication management and patient care.

Believe it or not, none of them are pharmacy specific.

FDA approves Uzedy, an extended-release injectable formulation of risperidone, enhancing treatment options for adults with bipolar I disorder.

Invasive lobular carcinoma poses unique challenges in detection and treatment, highlighting the urgent need for targeted research and improved survival strategies.

The pharmaceutical giant will reportedly lower its drug prices to align with most-favored-nation status.

Public debate intensifies as Robert F. Kennedy Jr compares selective serotonin reuptake inhibitors (SSRIs) to heroin, prompting mental health experts to clarify antidepressant use and withdrawal misconceptions.

A hybrid chatbot that evaluates stages of change in pneumococcal vaccination desires while providing artificial intelligence (AI)-based Q&A opportunities improved uptake in older adults.

The FDA approves Eydenzelt, a biosimilar for retinal diseases, enhancing treatment options for diabetic macular edema and age-related macular degeneration.

Discover groundbreaking FDA approvals for innovative treatments, including semaglutide for liver health and bumetanide nasal spray for heart failure.

Explore recent FDA-approved drugs from September 2025.

Combining tramadol with CYP2D6-inhibiting antidepressants raises seizure risk in older adults, highlighting the need for careful medication management.

Repetitive DNA mimics pathogens, influencing cancer immunity and immunotherapy.

Research reveals that poor glycemic control in adolescents with type 1 diabetes significantly increases the risk of developing neuropathy in adulthood.

Tramadol provides only limited pain relief while carrying a significant risk of serious adverse effects.

Hallucinatory affects associated with psychedelic drugs and Lewy body diseases may have some commonalities.

GLP-1 receptor agonists significantly influence FDG-PET-CT scan interpretations, potentially leading to misdiagnosis in cancer detection.

Many factors lead to policy change and market viability, but none more than perceived need and desire to receive a service.

As one of the most prescribed medications worldwide, proton pump inhibitor use could serve as a bulwark against severe outcomes in hospitalized adults with COVID-19.

Niraparib combined with standard therapy significantly improves progression-free survival in men with HRR-deficient metastatic castration-sensitive prostate cancer.